Andrey Antov, PhD, MBA

Dr Andrey Antov values the benefits of working within an interdisciplinary team to advance cancer care and help patients.

Dr Andrey Antov sees much potential for navigators when it comes to applying genetic and genomic testing to cancer care.

Dr Andrey Antov expands on how the healthcare team can work together to provide the best possible care for their patient.

Dr Andrey Antov recognizes how important the role of the navigator is in dealing with genetic and genomic testing, as the navigator often needs to help the patient gain access to the appropriate therapy, work with different stakeholders, monitor data, and more.

Dr Andrey Antov believes it's important for patients to participate in clinical trials for a multitude of reasons, as clinical trials can benefit both the patient and the healthcare system as a whole.

Dr Andrey Antov provides an overview of the role of Jackson Laboratory in the field of cancer genetic testing and in the education of nurses and navigators who co-manage patients at high risk or with a diagnosis of cancer.

Dr Andrey Antov muses on the evolution of genomics and how it could potentially impact targeted therapies and cancer care.

Dr Andrey Antov identifies situations in which people may want to consider genetic testing.

Dr Andrey Antov provides a useful metaphor to explain how genetic testing and genomic testing differ from one another and the purpose behind each type of testing.

Dr Andrey Antov notes that there is often confusion around genetic and genomic testing, due in part to a lack of genetic counselors, high costs, and the rate of adoption of new technologies.